Predictors Of Post-Operative Morbidity and Mortality After Debulking Surgeries For Gynaecological Malignancies.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Preoperative operative status
研究概览
简要总结
Indian population affected by gynaecological malignancies differs from western population in various aspects. The body habitus, preoperative nutritional status, comorbidity optimization, stage at presentation, follow up and adherence to the planned management protocol etc. may differ from the western population. Thus, the factors affecting surgical outcomes and further treatment plan after gynaecological cancer surgeries in the Indian population may be different from the current available data. This study aims to study predictors of post operative morbidity and mortality after gynaecological cancer resection in the Indian patient population.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 75.00 Year(s)(—)
- 性别
- Female
入选标准
- •Patients with ovarian/fallopian tube/primary peritoneal cancer posted for primary or interval cytoreductive surgery.
- •Patients with endometrial cancer or cervical cancer posted for radical hysterectomy.
- •Patients with undiagnosed adnexal masses posted for laparotomy, frozen section, and staging surgery.
排除标准
- •Patients with carcinoma of vagina or vulva posted for surgery.
- •Palliative surgeries and stoma formation.
结局指标
主要结局
Preoperative operative status
时间窗: Morbidity at 30 days and 90 days
Tumor status
时间窗: Morbidity at 30 days and 90 days
Intraoperative surgical parameters
时间窗: Morbidity at 30 days and 90 days
Post-operative complications
时间窗: Morbidity at 30 days and 90 days
30-day major morbidity
时间窗: Morbidity at 30 days and 90 days
次要结局
- Factors associated with 90-day mortality in patients undergoing debulking surgeries for gynecological malignancies(90 DAYS AFTER SURGERY)
- Factors associated with delay (beyond 42 days) in the start of adjuvant oncological therapy in patients undergoing debulking surgeries for gynecological malignancies(42 DAYS AFTER SURGERY)
研究者
SAURABH VIG
NCI, All Institute of Medical Sciences
